comparemela.com
Home
Live Updates
Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers : comparemela.com
Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers
Domvanalimab plus zimberelimab with chemotherapy demonstrated a positive overall response rate and 6-month progression free survival rate for patients with upper gastrointestinal cancers.
Related Keywords
United States
,
American
,
Yelenay Janjigian
,
,
Arcus Biosciences Inc
,
Domvanalimab Gilead Sciences Inc
,
Gilead Sciences Inc
,
American Society
,
Clinical Oncology Monthly Plenary
,
Gastrointestinal Medical Oncology Service
,
Memorial Sloan Kettering Cancer Center
,
Arcus Biosciences
,
comparemela.com © 2020. All Rights Reserved.